{{Rsnum
|rsid=12214416
|Gene=LPAL2
|Chromosome=6
|position=160489485
|Orientation=plus
|GMAF=0.0326
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=LPAL2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 0.0 | 8.8 | 91.2
| HCB | 0.0 | 8.8 | 91.2
| JPT | 0.0 | 5.4 | 94.6
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 8.8 | 91.2
| CHD | 0.0 | 5.5 | 94.5
| GIH | 0.0 | 10.9 | 89.1
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 13.8 | 86.2
| MKK | 0.0 | 0.6 | 99.4
| TSI | 0.0 | 11.8 | 88.2
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21900290
|Trait=None
|Title=Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes.
|RiskAllele=A
|Pval=5E-8
|OR=0.5000
|ORtxt=[0.32-0.68] decrease mg/dL
|OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}